Patient & Survivor Care
Commentary
Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics
Oncologist and gastroenterologist discuss treatment methods and guidelines for patients experiencing diarrhea from chemotherapy.
Conference Coverage
Savolitinib Active Against MET Ex14 Mutated NSCLC
Savolitinib was associated with similar progression-free survival as both first- and second-line therapy for patients with locally advanced or...
Latest News
New Guidance for the Treatment of Metastatic Breast Cancer
The ABC International Consensus Guidelines discuss situations in clinical practice that don’t have strong data suggesting the best path to take....
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
Conference Coverage
Minimally Invasive Cytoreductive Approach Comparable to Open Surgery for Ovarian Cancer
There were no differences in survival for patients with complete gross resections who underwent interval debulking via laparoscopy/robotics or...
Latest News
Subcutaneous Immunotherapy Promises Better Life For Cancer Patients
A move toward subcutaneous versions of standard biologics means less time in clinic for physicians and patients.
Conference Coverage
Lung Cancer Screening Unveils Hidden Health Risks
An ongoing trial is using lung cancer screening CT scans to also look for signs of impending heart disease in 24,000 Europeans.
Commentary
The Simple Change That Can Improve Patient Satisfaction
Eye contact and a physician sitting rather than standing lead to increased patient satisfaction in interactions.
Conference Coverage
Therapeutic HPV16 vaccine clears virus in most patients with CIN
An experimental vaccine delivered by electroporation cleared virus in 78% of women with CIN2/3 by 6 months.
Conference Coverage
Upfront Low-Dose Radiation Improves Advanced SCLC Outcomes
Researchers compared their new findings with those of standard first-line treatment results from the 2019 CASPIAN trial.
From the Journals
Most Cancer Trial Centers Located Closer to White, Affluent Populations
Researchers compare the distributions of patients of different races and socioeconomic statuses to the locations of clinical research facilities...